Changing prevalence of darunavir resistance-associated mutations (DRV RAMs) in clinical samples received for routine resistance testing: 2003-2009

por De La Rosa, G, Pattery, T, Picchio, G, Lathouwers, E, Villacian, J, Van der Borght , K
Publicado 2010

ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults

por Orkin, C, DeJesus, E, Khanlou, H, Stoehr, A, Supparatpinyo, K, Van de Casteele, T, Lathouwers, E, Spinosa-Guzman, S
Publicado 2010

Longitudinal changes in global structural brain connectivity and cognitive performance in former hospitalized COVID-19 survivors: an exploratory study

por Tassignon, B., Radwan, A., Blommaert, J., Stas, L., Allard, S. D., De Ridder, F., De Waele, E., Bulnes, L. C., Hoornaert, N., Lacor, P., Lathouwers, E., Mertens, R., Naeyaert, M., Raeymaekers, H., Seyler, L., Van Binst, A. M., Van Imschoot, L., Van Liedekerke, L., Van Schependom, J., Van Schuerbeek, P., Vandekerckhove, M., Meeusen, R., Sunaert, S., Nagels, G., De Mey, J., De Pauw, K.
Publicado 2023